Question from Deputy Ken O'Flynn - PQ 28066-26
Deputy O'Flynn asked for a detailed breakdown of reasons for rejected/unpaid pharmacy claims under the general medical services scheme. Read the HSE response.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Flynn asked for a detailed breakdown of reasons for rejected/unpaid pharmacy claims under the general medical services scheme. Read the HSE response.
Deputy O'Flynn asked about mechanisms that are in place to monitor rejection rates for commonly prescribed medicines. Read the HSE response.
Deputy Moynihan asked for update on the allocation of and recruitment to public health nursing posts in Dublin mid-west. Read the HSE response.
Deputy O'Flynn asked about any audit or validation exercise has been conducted on the accuracy/consistency of claim rejections by PCRS. Read the HSE response.
Deputy O'Flynn asked if rejected/unpaid claims for salbutamol nebules (2024/25) can be disaggregated from general rejection categories. Read the HSE response.
Deputy O'Flynn asked about alerts to identify significant increases in spend on specific medicines, including salbutamol nebules. Read the HSE response.
Deputy O'Flynn asked about whether benchmarking has been carried out comparing expenditure and utilisation of salbutamol nebules. Read the HSE response.
Deputy O'Flynn asked if PCRS maintains product-specific data on rejected or unpaid pharmacy claims. Read the HSE response.
Deputy O'Flynn asked about the treatment abroad scheme records total cost per patient episode since 2020. Read the HSE response.
Deputy O'Flynn asked about the reimbursement price per unit applicable to salbutamol nebules under PCRS 2024-2026. Read the HSE response.